Walleye Capital LLC Acadia Pharmaceuticals Inc Call Options Transaction History

Walleye Capital LLC

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$14.62 - $18.42 $293,862 - $370,242	20,100 Added 186.11%	30,900 $502,000
Q1 2024 May 15, 2024	BUY	$17.79 - $30.86 $188,574 - $327,116	10,600 Added 5300.0%	10,800 $199,000
Q4 2023 Feb 14, 2024	SELL	$20.78 - $31.77 $87,276 - $133,434	-4,200 Reduced 95.45%	200 $6,000
Q3 2023 Nov 14, 2023	BUY	$20.84 - $33.47 $91,696 - $147,268	4,400 New	4,400 $91,000
Q4 2022 Feb 14, 2023	SELL	$14.2 - $18.63 $56,800 - $74,520	-4,000 Reduced 39.6%	6,100 $97,000
Q3 2022 Nov 14, 2022	BUY	$14.11 - $18.27 $142,511 - $184,527	10,100 New	10,100 $165,000
Q1 2020 May 15, 2020	SELL	$31.65 - $46.87 $699,465 - $1.04 Million	-22,100 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$36.21 - $51.4 $644,538 - $914,920	17,800 Added 413.95%	22,100 $945,000
Q3 2019 Nov 14, 2019	SELL	$22.22 - $44.01 $713,262 - $1.41 Million	-32,100 Reduced 88.19%	4,300 $155,000
Q2 2019 Aug 14, 2019	BUY	$23.32 - $28.12 $848,848 - $1.02 Million	36,400 New	36,400 $973,000

280

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.65B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.